Johns Hopkins Glomerular Diseases Clinic

Overview

The Johns Hopkins Glomerular Diseases Clinic in the Division of Nephrology provides comprehensive and state-of-the-art care for all types of glomerular diseases. It is a collaborative effort between the members of the Divisions of Nephrology and Renal Pathology at Johns Hopkins University.

Director

Dr. C. John Sperati, Co-Director

Dr. Duvuru Geetha, Co-Director

Nephrologists

Dr. Mo Atta (Professor of Medicine)

Dr. Derek Fine (Professor of Medicine)

Dr. Duvuru Geetha (Professor of Clinical Medicine)

Dr. Manny Monroy-Trujillo (Assistant Professor of Medicine)

Dr. John Sperati (Associate Professor of Medicine)

Dr. Abbal Koirala (Assistant Professor of Medicine)

Nephropathologists

Dr. Avi Rosenberg (Assistant Professor of Pathology)

Dr. Dao-Fu Dai (Associate Professor of Pathology)

Dr. Serena Bagnasco (Professor of Pathology)

Active Clinical Trials

• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) (RAINIER)

• Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy

• A Study of the Efficacy and Safety of DMX-200 in Patients with FSGS who are Receiving an ARB (ACTION3)

• Study of Efficacy and Safety of LNP023 in Participants with Active Lupus Nephritis Class III-IV, +/- V

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants with APOL1-Mediated Proteinuric Kidney Disease (AMPLITUDE)

Current non-trial studies

• Johns Hopkins Precision Medicine Vasculitis Registry

• Cure Glomerulonephropathy (CureGN)

• Johns Hopkins Complement Associated Disease Registry (CADR)

Accepting trainee applications?

Completed an internal medicine residency program that is ACGME-accredited, an AOA-approved residency program, a program with ACGME International (ACGME-I) Advanced Specialty Accreditation, or a Royal College of Physicians and Surgeons of Canada (RCPSC)-accredited or College of Family Physicians of Canada (CFPC)-accredited residency program located in Canada.

Prior to appointment in the glomerular diseases fellowship, the fellow must complete an ACGME-accredited nephrology fellowship training program.

Applicants with US work authorization (J1, H1B, etc.) are eligible to apply

Visit their website: https://www.hopkinsmedicine.org/nephrology/education/fellowship-tracks